Medication info
Amlotelmi Tablet 40/5 Milligrams

Amlotelmi Tablet 40/5 Milligrams

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
A white and light blue, bi-convex, oval-shaped tablet.
Packaging
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201607340 · Approved 2016.12.28 · Insurance code 656004410

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, switching to this drug (a combination product containing the same amounts of each active ingredient) may be considered for convenience (limited to this drug 40/5 mg). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: Although the usual amlodipine dosage is recommended for elderly patients, caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In patients 75 years of age and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
◦ Children: Administration of this drug is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential Hypertension
View approved original text

This medication is used for patients with essential hypertension who do not achieve sufficient blood pressure control even when taking telmisartan or amlodipine alone. In other words, it helps manage blood pressure effectively in cases where existing treatments are insufficient.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, switching to this drug (a combination product containing the same amounts of each active ingredient) may be considered for convenience (limited to this drug 40/5 mg). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: Although the usual amlodipine dosage is recommended for elderly patients, caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In patients 75 years of age and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

◦ Children: Administration of this drug is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.

Precautions

This medication may pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, so it should not be taken by women who are pregnant or may become pregnant. Administration is contraindicated for patients with allergies to the active ingredient or related components, or with certain diseases such as liver, heart, or kidney conditions. Particularly, caution should be exercised in patients with impaired liver function, severe hypotension, or unstable cardiac function. While taking this medication, symptoms such as dizziness, edema, and hypotension may occur; if symptoms are severe, immediate consultation with a healthcare professional is advised. Because of its strong blood pressure-lowering effect, careful attention is needed for patients with insufficient fluid or salt, as hypotension may occur. This medication may elevate potassium levels, so blood potassium levels should be monitored regularly when taken with potassium supplements or potassium-rich foods. Patients with impaired kidney function may experience worsened kidney function, necessitating regular kidney function testing. Caution is advised during driving or operating hazardous machinery, as drowsiness or dizziness may lead to accidents. Interactions may occur when taken with other antihypertensive medications or certain drugs, so it's critical to inform healthcare professionals about all medications being taken. In cases of overdose, symptoms like severe hypotension or heart problems may arise, so the prescribed dosage must be strictly followed, and if any abnormal symptoms appear, immediate medical attention is required. This medication is not recommended for children due to insufficient data on safety and efficacy.

Side effects

  • Dizziness
  • peripheral edema
  • fainting
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory loss
  • taste disturbances
  • tremors
  • extrapyramidal disorders
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that protects it from light, at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

A white and light blue, bi-convex, oval-shaped tablet.

Package unit

30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.